Neuronetics Inc - Asset Resilience Ratio
Neuronetics Inc (STIM) has an Asset Resilience Ratio of 0.16% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Neuronetics Inc (STIM) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how Neuronetics Inc's Asset Resilience Ratio has changed over time. See Neuronetics Inc (STIM) shareholders funds for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Neuronetics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Neuronetics Inc market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $225.00K | 0.16% |
| Total Liquid Assets | $225.00K | 0.16% |
Asset Resilience Insights
- Limited Liquidity: Neuronetics Inc maintains only 0.16% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Neuronetics Inc Industry Peers by Asset Resilience Ratio
Compare Neuronetics Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for Neuronetics Inc (2019–2025)
The table below shows the annual Asset Resilience Ratio data for Neuronetics Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.16% | $225.00K | $141.55 Million | +0.01pp |
| 2024-12-31 | 0.15% | $206.00K | $140.90 Million | -0.64pp |
| 2023-12-31 | 0.78% | $905.00K | $115.83 Million | -0.53pp |
| 2022-12-31 | 1.32% | $1.54 Million | $116.88 Million | -0.24pp |
| 2021-12-31 | 1.56% | $2.20 Million | $141.22 Million | -0.84pp |
| 2020-12-31 | 2.40% | $1.89 Million | $78.66 Million | +1.52pp |
| 2019-12-31 | 0.88% | $880.00K | $100.17 Million | -- |
About Neuronetics Inc
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a p… Read more